Skip to main content

Evanescence & Five Finger Death Punch Eyeing Top Of Billboard 200 Chart

Evanescence's first new album in five years may be its second chart-topper.

After a long five-year wait, Evanescence is back-and perhaps headed for its second No. 1 on the Billboard 200 albums chart.

The band’s new self-titled third studio release could sell around 110,000 to 125,000 copies by week’s end on Sunday, Oct. 16–so say industry prognosticators.

While that is probably a big enough sales figure to secure a No. 1 arrival, don’t count out the resilient Adele and her “21” album. It sold 112,000 this past week according to Nielsen SoundScan, and has been moving between 110,000 to 154,000 on a weekly basis for the past month-and-a-half. “21” rose a spot to No. 2 on the Billboard 200 this week and has never left the top four positions since it bowed at No. 1 on March 12.

Evanescence’s new album, if it hits No. 1, will mark the Amy Lee-fronted group’s second chart-topper, following “The Open Door” in 2006. That album bounded in with 447,000 copies sold. “Door” was the follow-up to the rock act’s breakthrough debut, “Fallen,” which spent 106 weeks on the Billboard 200 and has sold 7.6 million copies in the U.S.


Another rock band, Five Finger Death Punch, could be cruising to a top three debut on the Billboard 200 as its third album, “American Capitalist,” may sell around 80,000 to 100,000. Its last release, 2009’s “War Is the Answer,” jumped in at No. 7 with a 44,000 launch. Its sales-to-date stand at 569,000.

2011 “American Idol” runner-up Lauren Alaina and Ryan Adams’ “Ashes & Fire” could both start in the top 10 as well-shifting about 60,000 and 50,000 copies each, respectively. Country superstar Martina McBride’s “Eleven” is flirting with a top 10 debut (perhaps 35,000) as is Joe Jonas’ solo debut “Fastlife” (maybe 25,000).